Brainstorm Cell Therapeutics (BCLI) Share-based Compensation (2010 - 2026)
Brainstorm Cell Therapeutics (BCLI) recorded Share-based Compensation of $2.24 million in Q2 2026, up 346.1% from $503,000 a year earlier.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Share-based Compensation (2010 - 2026) Analysis & Trends
On a TTM basis, Brainstorm Cell Therapeutics' Share-based Compensation came in at $2.68 million as of Jun 30, 2026, up 66.7% year-over-year; for FY2025, it came in at $1.52 million, up 102.7% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of -9.9% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $750,000 in FY2024 (-49.7%), $1.49 million in FY2023 (-11.4%), $1.68 million in FY2022 (+23.1%) and $1.37 million in FY2021 (-46.6%).
- The Q2 2026 figure is the highest quarterly Share-based Compensation in data going back to Q3 2010.
- On a year-over-year basis, Share-based Compensation rose in three of the last seven quarters, with growth averaging 90.7%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 346.1% in Q2 2026, against a decline of 99.2% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $133,000 (Q1 2026), $143,000 (Q4 2025) and $157,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | 2.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.24 Mn |
| Mar 31, 2026 | 133,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Jun 30, 2025 | 503,000.00 |
| Mar 31, 2025 | 717,000.00 |
| Dec 31, 2024 | 208,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 170,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Sep 30, 2023 | 548,000.00 |
| Jun 30, 2023 | 988,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 377,000.00 |
| Sep 30, 2022 | 395,000.00 |
| Jun 30, 2022 | 405,000.00 |
| Mar 31, 2022 | 505,000.00 |
| Dec 31, 2021 | 640,000.00 |
| Sep 30, 2021 | 196,000.00 |
API Access
Brainstorm Cell Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();